EUS引导肝内胆管引流补救不可切除恶性肝门胆管狭窄
本研究回顾性分析了2008年12月至2016年5月间30例Bismuth II级及以上不可切除恶性肝门胆管狭窄患者,在反复经乳头内镜干预失败后接受EUS引导肝内胆管引流(EUS-IBD)。技术成功率96.7%,临床成功率75.9%,轻度腹膜炎发生率10%,无操作相关死亡。多因素分析显示Bismuth IV型狭窄与临床无效相关(OR=12.7,95%CI 1.18-135.4,P=0.035)。
要点
- EUS-IBD在经乳头再干预失败的UMHBS患者中技术成功率达96.7%,临床成功率75.9%
- Bismuth IV型狭窄是EUS-IBD临床无效的预测因素(OR=12.7,P=0.035)
- 主要并发症为轻度腹膜炎(10%),可保守处理,无操作相关死亡
核心结论
- EUS-IBD可作为经乳头内镜再干预失败后UMHBS患者的可行且有效的补救方案,尤其适用于Bismuth II或III型狭窄。
研究设计与样本
- 回顾性分析2008年12月至2016年5月连续30例Bismuth II级及以上UMHBS患者,均在反复经乳头干预失败后接受EUS-IBD。
- 评估技术成功、临床成功和并发症率,并探索EUS-IBD临床无效的相关因素。
主要发现
- 技术成功29/30(96.7%),临床成功22/29(75.9%)。
- 轻度腹膜炎3/30(10%),保守处理;支架功能障碍7/30(23.3%);无操作相关死亡。
- 多因素分析Bismuth IV型狭窄预测临床无效(OR=12.7,95%CI 1.18-135.4,P=0.035)。
关键数值与推荐
- Bismuth II、III、IV型分别5、13、12例;既往内镜干预中位数4次(范围2-14)。
- EUS-IBD指征:十二指肠镜插入失败(n=4)、十二指肠支架置入后无法到达乳头(n=5)、无法实现目标肝内胆管引流(n=21)。
临床怎么用
- 对于反复经乳头内镜干预失败的UMHBS患者,可考虑EUS-IBD作为补救引流方式,Bismuth II或III型患者可能获益更明显。
局限性
- 回顾性单中心设计,样本量30例,结果需更大样本前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of unresectable malignant hilar biliary stricture (UMHBS) is challenging, especially after failure of repeated transpapillary endoscopic stenting. Endoscopic ultrasonography-guided intrahepatic biliary drainage (EUS-IBD) is a recent technique for intrahepatic biliary decompression, but indications for its use for complex hilar strictures have not been well studied. The aim of this study was to assess the feasibility and safety of EUS-IBD for UMHBS after failed transpapillary re-intervention. METHODS: Retrospective analysis of all consecutive patients with UMHBS of Bismuth II grade or higher who, between December 2008 and May 2016, underwent EUS-IBD after failed repeated transpapillary interventions. The technical success, clinical success, and complication rates were evaluated. Factors associated with clinical ineffectiveness of EUS-IBD were explored. RESULTS: A total of 30 patients (19 women, median age 66 years [range 52-87]) underwent EUS-IBD for UMHBS during the study period. Hilar biliary stricture morphology was classified as Bismuth II, III, or IV in 5, 13, and 12 patients, respectively. The median number of preceding endoscopic interventions was 4 (range 2-14). EUS-IBD was required because the following procedures failed: duodenal scope insertion (n = 4), accessing the papilla after duodenal stent insertion (n = 5), or achieving desired intrahepatic biliary drainage (n = 21). Technical success with EUS-IBD was achieved in 29 of 30 patients (96.7%) and clinical success was attained in 22 of these 29 (75.9%). Mild peritonitis occurred in three of 30 (10%) and was managed conservatively. Stent dysfunction occurred in 23.3% (7/30). There was no procedure-related mortality. On multivariable analysis, Bismuth IV stricture predicted clinical ineffectiveness (odds ratio = 12.7, 95% CI 1.18-135.4, P = 0.035). CONCLUSIONS: EUS-IBD may be a feasible and effective rescue alternative with few major complications after failed transpapillary endoscopic re-intervention in patients with UMHBS, particularly for Bismuth II or III strictures.
引用
- Minaga K, Takenaka M, Kitano M, et al. Rescue EUS-guided intrahepatic biliary drainage for malignant hilar biliary stricture after failed transpapillary re-intervention. Surg Endosc. 2017. PMID: 28424912. doi:10.1007/s00464-017-5553-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。